J2710 Neostigmine methylslfte injection
Also known as: neostigmine, prostigmin
Injection of neostigmine methylsulfate (Prostigmin), an anticholinesterase agent used for reversal of neuromuscular blockade and myasthenia gravis treatment.
In Plain Language
muscle strength medication
Clinical Context
Used to reverse neuromuscular blockade at end of surgery and for symptomatic treatment of myasthenia gravis.
RVU Information
CPT J2710 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2710?
CPT J2710 (Neostigmine methylslfte injection) is a J Codes (Drugs) code. Injection of neostigmine methylsulfate (Prostigmin), an anticholinesterase agent used for reversal of neuromuscular blockade and myasthenia gravis treatment.
How is J2710 administered?
CPT J2710 is administered by a healthcare provider, typically via injection or infusion. Used to reverse neuromuscular blockade at end of surgery and for symptomatic treatment of myasthenia gravis. It is used by Anesthesiology, Neurology.
When is CPT J2710 used?
Used to reverse neuromuscular blockade at end of surgery and for symptomatic treatment of myasthenia gravis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.